Teaching Workload

PHC 223 (Didactic Lecture and Case Study)

Immunopharmacology

Non-steroidal anti-inflammatory drugs (NSAIDs)

Opioid analgesics & antagonists & non-opioid analgesics

Antigout drugs

PHC 323 (Didactic Lecture and Case Study)

Rheumatoid Arthritis

Quantitative Pharmacokinetics

Local and General anaesthetics

PHA 426 (Didactic Lecture)

Principles of pharmaceutical biotechnology

Recombinant DNA Technology & Therapeutic Agents

Monoclonal Antibodies & Therapeutic Agents

Protein & Peptide Drugs

Manufacture and quality control of biologics

Antisense Therapeutic Agents

Gene Therapy

PHC 403 (Didactic Lecture)

Basic concepts and calculations in PK (19 hours/semester; 20 students; Didactic Lecture and Case Study)

Bioequivalence (BE) Studies

Drug dosing in special population

Therapeutic drug management

Dosing of specific drugs

Didactic and practical examples

Introduction to PKPD Modeling

PCL 305 (Didactic Lecture and Case Study)

Non-steroidal anti-inflammatory drugs (NSAIDs)

Opioid analgesics & antagonists & non-opioid analgesics

Antigout drugs

Diabetes and antidiabetic drugs

PAR815 Regulatory Sciences: Medical Devices

Introduction to the Regulation of Medical Devices

Medical Devices: Essential Requirements and Related Topics

Device Classification Systems in the EU and US

Evolution of Medical Device Legislation

International Standards and Recent Legislative Developments

Specific Issues in Medical Device Regulation

Marketing of Medical Devices and Diagnostics: Safety, Quality and Traceability

PAR814 Regulatory Sciences: Complementary and Traditional Medicines (CTMs)

Introduction to Complementary and Traditional Medicines

Characteristics of CTMs

The Status of CTMs in Their Countries of Origin

Challenges of Having Orthodox Medicines and CTMs in Parallel

National Regulatory Controls for CTMs

Compare and Critique the Regulatory Controls for CTMs

Proposed South African Regulations for CTMs

The Essential Components of a National Regulatory Framework for CTM

The Role, Values and Issues Relating to a National Regulatory Framework for CTMs